Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cerebrospinal Fluid Restores Vision

01.11.2004


A new method for visual impairment treatment has been discovered by researchers of the Institute of Human Brain, Russian Academy of Sciences. The patients suffering from visual impairment can be helped if a healthy donor’s cerebrospinal fluid is introduced to the parent’s vertebral canal – this method is called liquortransfusion. Physiologists have determined that the method is effective even when prescription of visual impairment exceeds five years. Eyesight improves with 83 percent of patients.



The reasons that deprive people of the ability for normal vision are multifarious – these are not only eye diseases, but also lesions of optic nerve, visual tracts and visual centers in the cerebrum. Till recently, physicians believed that effective treatment of visual system was possible only at early stages when no more than three months elapsed since the onset. Treatment at later stages was normally unsuccessful. Now physicians have the opportunity to restore vision of the patients who suffered visual impairment five and more years ago.

The method of endolumbal introduction (into the vertebral canal) of a healthy donor’s cerebrospinal fluid has been applied for several years already by specialists of the Institute of Human Brain, Russian Academy of Sciences. They have taken out a patent of the Russian Federation for application of this method for treatment of heavy neurologic patients who lost the ability for normal seeing. The donors are healthy volunteers, usually relatives of the patients. The cerebrospinal fluid (liquor) is transfused either immediately after it is taken from the donor or after short-term conservation and sterilization. Likewise blood transfusion, the group should be taken into account – the researchers have discovered four groups of cerebrospinal fluid (liquor) similar to four groups of blood.


Specialists state that one transfusion is sufficient to improve vision, in some cases the transfusion is repeated in several months. Vision is effectively restored with 83 percent of patients within the first two years after the disease onset, and at later stages - in 67.5 percent of cases. The researchers emphasize that treatment effectiveness does not significantly depend on the cause of the disease. The majority of patients experience vision improvement within the first two weeks after the procedure. Later on, vision rate continues to improve. Regardless of the visual system lesions degree, the general treatment response consists in expanding the field of vision. Even in case of amaurosis or if only light sensitivity is retained, it is possible to restore the outline vision and even subject vision after the cerebrospinal fluid (liquor) has been transfused.

The researchers explain the medicinaleffect of the donor cerebrospinal fluid by the presence of the substances similar to drugs in it – i.e., neuropeptides, which impact positively the systems of neural and neurohumoral regulation of the patient’s brain. These substances cause plastic rearrangements in the unaffected parts of the brain, and change interaction of various celebral structures that ensure visual functions. That allows the brain to make up the existing defects.

Clinical observations have proved that the cerebrospinal fluid (liquor) transfusion promotes electric cerebral biocurrents and initiates reorganization processes in the visual zone of the cerebral cortex and in the central nervous system as a whole. Neurohumoral regulation is evident in the fact that previously formed pathological relationship between cerebral portions gets suppressed and new relationship originates, which enables the visual system to function normally.

Sergey Komarov | alfa
Further information:
http://www.informnauka.ru

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>